Use of Adjunctive Aerosolized Antimicrobial Therapy in the Treatment of Pseudomonas aeruginosa and Acinetobacter baumannii Ventilator-Associated Pneumonia

References

1. 1.↵
   1. Restrepo MI,
   2. Anzueto A,
   3. Arroliga AC,
   4. Afessa B,
   5. Atkinson MJ,
   6. Ho NJ,
   7. et al

   . Economic burden of ventilator-associated pneumonia based on total resource utilization. Infect Control Hosp Epidemiol 2010;31(5):509-515.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Safdar N,
   2. Dezfulian C,
   3. Collard H,
   4. Saint S

   . Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med 2005;33(10):2184-2193.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   1. Trouillet JL,
   2. Chastre J,
   3. Vuagnat A,
   4. Joly-Guillou ML,
   5. Combaux D,
   6. Dombret MC,
   7. Gibert C

   . Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 1998;157(2):531-539.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   Infectious Diseases Society of America. Bad bugs, no drugs: as antibiotic discovery stagnates, a public health crisis brews. Alexandria, VA: Infectious Diseases Society of America; 2004. http://www.idsociety.org/uploadedFiles/IDSA/Policy_and_Advocacy/Current_Topics_and_Issues/Antimicrobial_Resistance/10x20/Images/Bad%20Bugs%20no%20Drugs.pdf. Accessed May 22, 2012.
5. 5.↵
   Infectious Diseases Society of America. The 10 x ‘20 Initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020. Clin Infect Dis 2010;50(8):1081-1083.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Rattanaumpawan P,
   2. Lorsutthitham J,
   3. Ungprasert P,
   4. Angkasekwinai N,
   5. Thamlikitkul V

   . Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria. J Antimicrob Chemother 2010;65(12):2645-2649.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Czosnowski QA,
   2. Wood GC,
   3. Magnotti LJ,
   4. Croce MA,
   5. Swanson JM,
   6. Boucher BA,
   7. Fabian TC

   . Adjunctive aersolized antibiotics for treatment of ventilator-associated pneumonia. Pharmacotherapy 2009;29(9):1054-1060.

   OpenUrlPubMed
8. 8.↵
   1. Kofteridis DP,
   2. Alexopoulou C,
   3. Valachis A,
   4. Maraki S,
   5. Dimopoulou D,
   6. Georgopoulos D,
   7. Samonis G

   . Aerosolized plus intravenous colistin versus intravenous colistin alone for the treatment of ventilator-associated pneumonia: a matched case-control study. Clin Infect Dis 2010;51(11):1238-1244.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Pingleton SK,
   2. Fagon JY,
   3. Leeper KV Jr.

   . Patient selection for clinical investigation of ventilator-associated pneumonia. Criteria for evaluating diagnostic techniques. Chest 1992;102(5 Suppl 1):553S-556S.

   OpenUrlPubMed
10. 10.↵
    1. Pugin J,
    2. Auckenthaler R,
    3. Mili N,
    4. Janssens JP,
    5. Lew PD,
    6. Suter PM

    . Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic “blind” bronchoalveolar lavage fluid. Am Rev Respir Dis 1991;143(5):1121-1129.

    OpenUrlCrossRefPubMedWeb of Science
11. 11.↵
    1. Michalopoulos A,
    2. Fotakis D,
    3. Virtzili S,
    4. Vletsas C,
    5. Raftopoulou S,
    6. Mastora Z,
    7. Falagas ME

    . Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study. Respir Med 2008;102(3):407-412.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    1. Luyt CE,
    2. Clavel M,
    3. Guntupalli K,
    4. Johannigman J,
    5. Kennedy JI,
    6. Wood C,
    7. et al

    . Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia. Crit Care 2009;13(6):R200.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Palmer LB,
    2. Smaldone GC,
    3. Chen JJ,
    4. Baram D,
    5. Duan T,
    6. Monteforte M,
    7. et al

    . Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit. Crit Care Med 2008;36(7):2008-2013.

    OpenUrlPubMedWeb of Science
14. 14.↵
    1. Lu Q,
    2. Yang J,
    3. Liu Z,
    4. Gutierrez C,
    5. Aymard G,
    6. Rouby JJ

    ; the Nebulized Antibiotics Study Group. Nebulized ceftazidime and amikacin in ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Am J Respir Crit Care Med 2011;184(1):106-115.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. Wood GC,
    2. Underwood EL,
    3. Croce MA,
    4. Swanson JM,
    5. Fabian TC

    . Treatment of recurrent Stenotrophomonas maltophilia ventilator-associated pneumonia with doxycycline and aerosolized colistin. Ann Pharmacother 2010;44(10):1665-1668.

    OpenUrlCrossRefPubMed
16. 16.↵
    1. Johnson M,
    2. Reichley R,
    3. Hoppe-Bauer J,
    4. Micek ST,
    5. Kollef MH

    . Impact of previous antibiotic therapy on outcome of Gram-negative severe sepsis. Crit Care Med 2011;39(8):1859-1865.

    OpenUrlCrossRefPubMedWeb of Science
17. 17.↵
    1. Luyt CE,
    2. Combes A,
    3. Nieszkowska A,
    4. Trouillet JL,
    5. Chastre J

    . Aerosolized antibiotics to treat ventilator-associated pneumonia. Curr Opin Infect Dis 2009;22(2):154-158.

    OpenUrlCrossRefPubMedWeb of Science
18. 18.↵
    1. Iregui M,
    2. Ward S,
    3. Sherman G,
    4. Fraser VJ,
    5. Kollef MH

    . Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002;122(1):262-268.

    OpenUrlCrossRefPubMedWeb of Science
19. 19.↵
    1. Ryan G,
    2. Singh M,
    3. Dwan K

    . Inhaled antibiotics for long-term therapy in cystic fibrosis. Cochrane Database Syst Rev 2011;(3):CD001021.